Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats

American Journal of Nephrology

Volumn 24, Issue 6, 2004, Pages 614-623

  Toblli, Jorge Eduardo ^a   Stella, Inés ^b   Mazza, Osvaldo Néstor ^a   Ferder, León ^b   Inserra, Felipe ^b  

^a HOSPITAL ALEMÁN   (Argentina)

^b Inst de Invest Cardiologicas   (Argentina)

Author keywords

Amlodipine; Angiotensin II receptor antagonists; Corpus cavernous; Erectile dysfunction; Spontaneously hypertensive rats

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR 1 ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; COLLAGEN TYPE 3; LOSARTAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORPUS CAVERNOSUM; CORRELATION ANALYSIS; DRUG EFFECT; EVALUATION; HEART LEFT VENTRICLE MASS; HYPERTENSION; MALE; MYOFIBROSIS; NONHUMAN; PENIS; PENIS ARTERY; PENIS ERECTION; PRIORITY JOURNAL; PROTECTION; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIES; DRUG THERAPY, COMBINATION; HYPERTENSION, RENAL; HYPERTROPHY; IMPOTENCE; LOSARTAN; MALE; MUSCLE, SMOOTH, VASCULAR; PENIS; PROTEINURIA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATOR AGENTS;

EID: 13244252617     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082598     Document Type: Article

References (29)

1. Burchardt M, Burchardt T, Anastasiadis AG, Kiss AJ, Shabsigh A, de La Taille A, Pawar RV, Baer L, Shabsigh R: Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res 2001;13:276-281.
2. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, de la Taille A, Hayek OR, Shabsigh R: Hypertension is associated with severe erectile dysfunction. J Urol 2000;164:1188-1191.
3. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB: Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-463.
4. Ferrario CM, Levy P: Sexual dysfunction in patients with hypertension: Implications for therapy. J Clin Hypertens 2002;4:424-432.
5. Toblli JE, Stella I, Inserra F, Ferder L, Zeller FL, Mazza ON: Morphologic changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000;13:686-692.
6. Chitaley K, Webb RC, Dorrance AM, Mills TM: Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001;13(suppl 5):S16-S20.
7. Brock GB, Lue TF: Drug induced male sexual dysfunction. Drug Safety 1993;8:414-426.
8. Adams MA, Banting JD, Maurice DH, Morales A, Heaton JP: Vascular control mechanisms in penile erection: Phylogeny and the inevitability of multiple and overlapping systems. Int J Impot Res 1997;9:85-91.
9. Berhr-Roussel D, Chamiot-Clerc P, Bernabe J, Mevel K, Alexandre L, Safar ME, Giuliano F: Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R682-R688.
10. Azadzoi KM, Siroky MB, Goldstein I: Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996;155:1795-1800.
11. Azadzoi KM, Goldstein I, Siroky MB: Relationship between cavernosal ischemia and corporeal veno-occlusive dysfunction in an animal model. J Urol 1997;157:1011-1017.
12. Andersson KE, Wagner G: Physiology of penile erection. Physiol Rev 1995;75:191-236.
13. Ushiyama M, Morita T, Kuramochi T, Yagi S, Katayama S: Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 2004;27:253-261.
14. Wespes E, Goes PM, Schiffmann S, Depierreux M, Vanderhaeghen JJ, Schulman CC: Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol 1991;146:1015-1017.
15. Persson C, Diederichs W, Lue TF, Yen TSB, Fishman IJ, Mc Lin PH, Tanagho EA: Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol 1989;142:1462-1468.
16. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
17. Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P, Dluhy RG: Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 1997;157:1920-1925.
18. Park JK, Kim SZ, Kim SH, Park YK, Cho KW: Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors. J Urol 1997;158:653-658.
19. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U: Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 2001;58:805-810.
20. Stanley AG, Patel H, Knight AL, Williams B: Mechanical strain-induced human vascular matrix synthesis: The role of angiotensin II. J Renin Angiotensin Aldosterone Syst 2000;1:32-35.
21. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin-II-induced but not catecholamine-induced hypertension. Circulation 1997;95:588-593.
22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured smooth muscle cells. Circ Res 1994;74:1141-1148.
23. Schiffrin EL, Park JB, Intengan HD, Touyz RM: Correlation of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000;101:1653-1659.
24. Sharifi AM, Li JS, Endemann D, Schiffrin EL: Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998;16:457-466.
25. Wenzel RR, Noll G, Luscher TF: Endothelial regulation of vascular tone and growth: Role of calcium antagonists; in Epstein M (ed): Calcium Antagonists in Clinical Medicine, ed 3. Philadelphia, Hanley & Belfus, 2002, pp 41-57.
26. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA 1996;93:5478-5482.
27. Hale TM, Okabe H, Heaton JPW, Adams MA: Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001;166:739-745.
28. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, Mugellini A: Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002;58:177-180.
29. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CA: Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001;321:336-341.